Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collection.
Edwards DM, Gharzai LA, Wang W, Mayo C, Suresh K, Schipper M, Evans JR, Malloy K, Chinn SB, Prince M, Spector M, Shuman A, Stucken C, Swiecicki PL, Worden F, Jarema J, Henderson C, Kovach A, Brenner C, Shah JL, Mierzwa ML, Casper K. Edwards DM, et al. Among authors: mierzwa ml. Head Neck. 2024 Apr 29. doi: 10.1002/hed.27778. Online ahead of print. Head Neck. 2024. PMID: 38680087
Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Hawkins PG, Mierzwa ML, Bellile E, Jackson WC, Malloy KM, Chinn SB, Spector ME, Shuman AG, Stucken CL, McLean SA, Bradford CR, Prince ME, Carey TE, Worden FP, Swiecicki PL, Taylor JMG, Wolf GT, Eisbruch A, Casper KA. Hawkins PG, et al. Among authors: mierzwa ml. Head Neck. 2019 Apr;41(4):857-864. doi: 10.1002/hed.25336. Epub 2019 Feb 18. Head Neck. 2019. PMID: 30775826 Free PMC article.
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.
Swiecicki PL, Li P, Bellile E, Stucken C, Malloy K, Shuman A, Spector ME, Chinn S, Casper K, McLean S, Moyer J, Chepeha D, Wolf GT, Prince M, Bradford C, Nyati M, Eisbruch A, Worden FP, Jolly S, Mierzwa M. Swiecicki PL, et al. Head Neck. 2020 Aug;42(8):1728-1737. doi: 10.1002/hed.26085. Epub 2020 Jan 27. Head Neck. 2020. PMID: 31989702 Free PMC article. Clinical Trial.
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.
Swiecicki PL, Bellile E, Casper K, Chinn SB, Dragovic AF, Jolly S, Kupfer R, Malloy KM, Mierzwa ML, Shuman AG, Spector ME, Srinivasan A, Stucken C, Bradford CR, Eisbruch A, Carey TE, Prince ME, Wolf GT, Worden FP. Swiecicki PL, et al. Among authors: mierzwa ml. Head Neck. 2022 Jul;44(7):1509-1519. doi: 10.1002/hed.27043. Epub 2022 Apr 13. Head Neck. 2022. PMID: 35416374 Free PMC article. Clinical Trial.
Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancer.
Smith JD, Ludwig ML, Bhangale AD, Brummel C, Swiecicki PL, Worden FP, Chinn SB, Stucken CL, Rosko AJ, Prince MEP, Malloy KM, Casper KA, Bradford CR, Chepeha DB, Shah J, Schonewolf CA, McHugh JB, Nyati MK, Eisbruch A, Mierzwa ML, Spector ME, Brenner JC. Smith JD, et al. Among authors: mierzwa ml. Head Neck. 2023 May;45(5):1281-1287. doi: 10.1002/hed.27344. Epub 2023 Mar 18. Head Neck. 2023. PMID: 36932871 Clinical Trial.
Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.
Smith JD, Birkeland AC, Rosko AJ, Hoesli RC, Foltin SK, Swiecicki P, Mierzwa M, Chinn SB, Shuman AG, Malloy KM, Casper KA, McLean SA, Wolf GT, Bradford CR, Prince ME, Brenner JC, Spector ME. Smith JD, et al. Head Neck. 2019 Feb;41(2):423-428. doi: 10.1002/hed.25444. Epub 2018 Dec 12. Head Neck. 2019. PMID: 30548484 Free PMC article.
Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.
Beeler WH, Bellile EL, Casper KA, Jaworski E, Burger NJ, Malloy KM, Spector ME, Shuman AG, Rosko A, Stucken CL, Chinn SB, Dragovic AF, Chapman CH, Owen D, Jolly S, Bradford CR, Prince MEP, Worden FP, Jagsi R, Mierzwa ML, Swiecicki PL. Beeler WH, et al. Among authors: mierzwa ml. Oral Oncol. 2020 Feb;101:104521. doi: 10.1016/j.oraloncology.2019.104521. Epub 2019 Dec 23. Oral Oncol. 2020. PMID: 31877502 Free PMC article.
Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapy.
Heft Neal ME, Brennan J, Haring CT, Brenner JC, Worden F, Swiecicki P, Mierzwa M, Casper KA, Malloy KM, Stucken CL, McLean SA, Prince ME, Bradford CR, Wolf GT, Shuman AG, Chinn SB, Chepeha DB, Rosko AJ, Spector ME. Heft Neal ME, et al. Eur Arch Otorhinolaryngol. 2020 Jul;277(7):2085-2093. doi: 10.1007/s00405-020-05913-z. Epub 2020 Mar 19. Eur Arch Otorhinolaryngol. 2020. PMID: 32193723 Free PMC article.
90 results